LifeScience Biologics
DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...
April 14, 2026 | News
Telix and Regeneron to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model. Collabora...
April 14, 2026 | News
AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, announced that two key research abstracts regarding its lead co...
April 14, 2026 | Report
Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with AbbVie (NYSE: ABBV), a...
April 14, 2026 | News
Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...
April 13, 2026 | News
NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100K proteomics project. In this role, NovogeneAIT...
April 13, 2026 | News
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...
April 13, 2026 | News
Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...
April 13, 2026 | News
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with Precision Health Research, S...
April 10, 2026 | News
Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...
April 10, 2026 | News
-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...
April 09, 2026 | News
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...
April 09, 2026 | News
Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...
April 09, 2026 | News
Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...
April 09, 2026 | News
Most Read
Bio Jobs
News